Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB Transplant for Infant Leukemia and MDS
NCT00357565Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Nov 2005
- Primary completion
- Jun 2024
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), sponsored by Masonic Cancer Center. Started Nov 2005; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00357565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357565.